跳至主要内容
临床试验/EUCTR2009-011418-68-DE
EUCTR2009-011418-68-DE进行中(未招募)不适用

Pilotstudie zur Anwendung eines pflanzlichen Kombinationspräparats bei Frauen mit Reizblase (Overactive Bladder-Syndrom).(Translation: Pilot-Study with a herbal combination in women suffering from the overactive bladder syndrome (irritable bladder)). - femina study

GlaxoSmithKline Consumer Healthcare GmbH & Co. KG0 个研究点开始时间: 2009年8月13日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • Women aged = 18 = 60 years
  • >= 8 micturions during 24 hours (average according diary over 3 days)
  • >= 1 episode of urge or urge incontinence in 24 hours (average according diary over 3 days)
  • overactive bladder symptoms consist since at least 3 months
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Diseases and conditions that may cause secondary irritable bladder or cause any other micturition complaints
  • Bladder cancer
  • Unexplained hematuria
  • Severe renal diseases
  • Severe hepatic diseases
  • Known hypersensitivity to ingredients of the study medication

研究者

相似试验

已完成
不适用
A pilot study to evaluate the efficacy of combined transplantation of progenitor cells and coronary artery bypass graftingSurgery: Coronary artery bypass grafting (CABG)Surgery
ISRCTN75217135Department of Health10
进行中(未招募)
不适用
A pilot study investigating the effects of a combination of local and systemic anti-inflammatory adjuncts in patients undergoing vitrectomy and silicone oil for established Proliferative Vitreoretinopathy. - Anti-inflammatories in patients with PVRProliferative Vitreoretinopathy This is a scarring process that occurs in patients who have developed a retinal detachment. It is the primary cause of failure in retinal detachment surgery and occurs in 5-10% cases.
EUCTR2004-001991-37-GBMoorfields Eye Hospital30
进行中(未招募)
1 期
The influence of the medication Willfact on the blood loss of patient during the use of a heart-lung machineVon Willebrand Disease (VWD)MedDRA version: 19.1Level: PTClassification code 10069495Term: Acquired Von Willebrand's diseaseSystem Organ Class: 10005329 - Blood and lymphatic system disorders
EUCTR2016-000789-53-ATMedizinische Universität Innsbruck / Univ.-Klinik für Allgemeine und Chirurgische Intensivmedizin
已完成
不适用
Testing strategies to improve breathlessness and related symptoms in people with lung cancerLung cancer
ACTRN12612000925842Queensland University of Technology18
招募中
2 期
A study of TG4001 and avelumab cancer immunotherapies in advanced HPV-induced malignancies
2024-515119-23-00Transgene142